Cargando…

Is fatty liver a risk marker for heart failure?

Detalles Bibliográficos
Autor principal:	VanWagner, Lisa B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626010/ https://www.ncbi.nlm.nih.gov/pubmed/28745023 http://dx.doi.org/10.1002/oby.21901

Ejemplares similares

Survival effects of physical activity on mortality among persons with liver disease()
por: Loprinzi, Paul D., et al.
Publicado: (2015)

Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study
por: Gerber, Yariv, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

Dapagliflozin-Induced Acute-on-Chronic Liver Injury
por: Levine, Joshua A., et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Measures of Early Brain Health in Middle Aged Adults: The CARDIA study
por: VanWagner, Lisa B., et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Fudim, Marat, et al.
Publicado: (2021)

Young Adult Physical Activity Trajectories and Midlife Nonalcoholic Fatty Liver Disease
por: de Brito, Junia N., et al.
Publicado: (2023)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Lean NAFLD: A not so benign condition?
por: VanWagner, Lisa B., et al.
Publicado: (2018)

Longitudinal Association of Non‐Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study
por: VanWagner, Lisa B., et al.
Publicado: (2020)

A paradigm for fostering patient-centered research in liver disease: The liver transplant patient-engagement program
por: Lieber, Sarah R., et al.
Publicado: (2023)

2111: Insulin resistance patterns over 25-years of adulthood and nonalcoholic fatty liver disease in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
por: VanWagner, Lisa B., et al.
Publicado: (2018)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Aerobic and Muscle-Strengthening Physical Activity, Television Viewing, and Nonalcoholic Fatty Liver Disease: The CARDIA Study
por: McDonough, Daniel J., et al.
Publicado: (2023)

Resting and Exercise Energy Metabolism After Liver Transplantation for Nonalcoholic Steatohepatitis
por: Levitsky, Josh, et al.
Publicado: (2017)

Development of a Predictive Model for Hyperglycemia in Nondiabetic Recipients After Liver Transplantation
por: Zelada, Henry, et al.
Publicado: (2018)

Metabolic Dysfunction-associated fatty liver disease and incident heart failure risk: the Kailuan cohort study
por: Wei, Zhihao, et al.
Publicado: (2023)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
por: Han, Byoungduck, et al.
Publicado: (2022)

Fatty fish, marine omega-3 fatty acids, and incidence of heart failure
por: Levitan, Emily B., et al.
Publicado: (2010)

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review
por: Ismaiel, Abdulrahman, et al.
Publicado: (2019)

Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients
por: Harrington, Claire, et al.
Publicado: (2022)

When the heart kills the liver: acute liver failure in congestive heart failure
por: Saner, FH, et al.
Publicado: (2009)

The Liver in Heart Failure: From Biomarkers to Clinical Risk
por: Aspromonte, Nadia, et al.
Publicado: (2023)

Association between non-alcoholic fatty liver disease and risk of incident heart failure: a meta-analysis of observational studies
por: Li, Wensheng, et al.
Publicado: (2022)

Inflammation as a Prognostic Marker in Heart Failure
por: Lima, Priscila C, et al.
Publicado: (2022)

Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance
por: Zhang, Zichuan, et al.
Publicado: (2018)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure
por: Zheng, Sulin, et al.
Publicado: (2022)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart
por: Toko, Haruhiro, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients
por: Roderburg, Christoph, et al.
Publicado: (2023)

Posterior Inferior Cerebellar Infarct in a Younger Adult Male with Vertigo and Ataxia
por: VanWagner, Angela J., et al.
Publicado: (2017)

Prognostic value of the liver fibrosis marker fibrosis‐5 index in patients with acute heart failure
por: Maeda, Daichi, et al.
Publicado: (2022)

Midline Longitudinal Sacral Fracture in an Anterior-Posterior Compression Pelvic Injury -A Surgical Decision-making and Outcome
por: O’Neill, Nicholas, et al.
Publicado: (2019)

Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
por: Khanna, Sahil, et al.
Publicado: (2022)

When evidence is lacking: a mixed-methods approach for the development of practice guidance in liver transplantation
por: VanWagner, Lisa B, et al.
Publicado: (2020)

Fatty Liver and Fatty Heart—Where do They Stand in the AMIS Syndrome?
por: Lautt, W. Wayne, et al.
Publicado: (2015)

Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
por: Grassi, Guido, et al.
Publicado: (2022)

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
por: van den Berg, Pieter F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ja9f162u6jct6nasc3626bild7